| | | | | | | |
 | JOHNSON & JOHNSON | 1.46% | 5.63% | 6.56% | 11.58% | 27.42% | 479 678 |
| ELI LILLY AND COMPANY | 4.13% | 8.56% | 17.88% | 39.77% | 181.61% | 293 110 |
| PFIZER, INC. | 2.99% | 5.50% | -12.63% | 31.64% | 17.89% | 289 466 |
 | ROCHE HOLDING AG | 4.08% | 5.09% | -15.91% | -7.07% | 15.40% | 272 090 |
| ABBVIE INC. | 1.93% | 10.17% | 12.51% | 32.77% | 94.19% | 269 202 |
 | NOVO NORDISK A/S | 3.07% | 5.25% | 6.98% | 53.10% | 135.45% | 253 053 |
| MERCK & CO., INC. | 1.23% | 10.06% | 21.52% | 21.96% | 8.91% | 235 508 |
 | ASTRAZENECA PLC | 3.93% | 9.37% | 24.31% | 28.20% | 67.57% | 205 217 |
| NOVARTIS AG | 3.03% | 2.05% | 0.40% | -5.27% | -10.66% | 183 371 |
| BRISTOL-MYERS SQUIBB COMPANY | 1.63% | 6.98% | 26.64% | 19.91% | 72.85% | 168 111 |
 | SANOFI | 5.02% | 6.79% | 13.52% | 14.79% | 30.39% | 132 461 |
| AMGEN INC. | 0.94% | 4.54% | 9.07% | 1.83% | 32.75% | 131 077 |
| GSK PLC | 2.00% | 4.18% | 9.17% | 24.31% | 10.11% | 109 224 |
 | BAYER AG | -1.28% | -7.61% | 22.96% | 12.65% | 4.43% | 59 888 |
 | DAIICHI SANKYO CO., LTD. | 2.29% | 8.24% | 13.23% | 35.57% | 66.24% | 46 990 |
| | | | | | | |
| | Gemiddelde | 2.43% | 5.65% | 10.41% | 21.05% | 50.30% | |
| | Gewogen gemiddelde per kap. | 2.60% | 6.39% | 8.35% | 21.52% | 55.76% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
